{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T01:46:37Z","timestamp":1783647997147,"version":"3.55.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T00:00:00Z","timestamp":1726012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T00:00:00Z","timestamp":1726012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Otorhinolaryngol"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s00405-024-08965-7","type":"journal-article","created":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T08:28:43Z","timestamp":1726043323000},"page":"993-1003","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Comparison of prognosis between oncocytic thyroid carcinoma and follicular thyroid carcinoma: a population-based propensity score matching analysis"],"prefix":"10.1007","volume":"282","author":[{"given":"Hao","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He-Lin","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Lu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu-Lin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2442-2454","authenticated-orcid":false,"given":"Jun","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,11]]},"reference":[{"key":"8965_CR1","first-page":"30","volume":"8","author":"QT Nguyen","year":"2015","unstructured":"Nguyen QT, Lee EJ, Huang MG et al (2015) Diagnosis and treatment of patients with thyroid cancer. Am Health Drug Benefits 8:30\u201340","journal-title":"Am Health Drug Benefits"},{"key":"8965_CR2","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1001\/jamaoto.2014.1","volume":"140","author":"L Davies","year":"2014","unstructured":"Davies L, Welch HG (2014) Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg 140:317\u2013322","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"8965_CR3","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/S2213-8587(17)30325-X","volume":"6","author":"G Grani","year":"2018","unstructured":"Grani G, Lamartina L, Durante C et al (2018) Follicular thyroid cancer and H\u00fcrthle cell carcinoma: challenges in diagnosis, treatment, and clinical management. Lancet Diabetes Endocrinol 6:500\u2013514","journal-title":"Lancet Diabetes Endocrinol"},{"key":"8965_CR4","doi-asserted-by":"publisher","first-page":"791826","DOI":"10.3389\/fendo.2022.791826","volume":"13","author":"MH Wu","year":"2022","unstructured":"Wu MH, Lee YY, Lu YL et al (2022) Risk factors and prognosis for metastatic follicular thyroid cancer. Front Endocrinol 13:791826","journal-title":"Front Endocrinol"},{"issue":"6","key":"8965_CR5","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.surg.2013.06.029","volume":"154","author":"S Nagar","year":"2013","unstructured":"Nagar S, Aschebrook-Kilfoy B, Kaplan EL et al (2013) Hurthle cell carcinoma: an update on survival over the last 35 years. Surgery 154(6):1263\u20131271","journal-title":"Surgery"},{"key":"8965_CR6","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1002\/cncr.27770","volume":"119","author":"P Goffredo","year":"2013","unstructured":"Goffredo P, Roman SA, Sosa JA (2013) Hurthle cell carcinoma: a population-level analysis of 3311 patients. Cancers 119:504\u2013511","journal-title":"Cancers"},{"key":"8965_CR7","first-page":"e30298","volume":"14","author":"A Syed","year":"2022","unstructured":"Syed A, Vanka SA, Escudero I et al (2022) Oncocytic cell carcinoma of the thyroid: a case report and an overview of the diagnosis. Treat Modalities Progn 14:e30298","journal-title":"Treat Modalities Progn"},{"key":"8965_CR8","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3390\/cancers13010026","volume":"13","author":"S Kure","year":"2020","unstructured":"Kure S, Ohashi R (2020) Thyroid H\u00fcrthle cell carcinoma: clinical, pathological, and molecular features. Cancers 13:26","journal-title":"Cancers"},{"key":"8965_CR9","volume-title":"Hurthle cell thyroid carcinoma","author":"MM Fariduddin","year":"2023","unstructured":"Fariduddin MM, Syed W (2023) Hurthle cell thyroid carcinoma. StatPearls Publishing, Treasure Island"},{"key":"8965_CR10","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s12022-018-9548-1","volume":"29","author":"T Janovitz","year":"2018","unstructured":"Janovitz T, Barletta JA (2018) Clinically relevant prognostic parameters in differentiated thyroid carcinoma. Endocr Pathol 29:357\u2013364","journal-title":"Endocr Pathol"},{"issue":"5","key":"8965_CR11","first-page":"908","volume":"63","author":"C Hedinger","year":"1989","unstructured":"Hedinger C, Williams ED, Sobin LH (1989) The WHO histological classification of thyroid tumors: a commentary on the second edition. Cancer Am Cancer Soc 63(5):908\u2013911","journal-title":"Cancer Am Cancer Soc"},{"key":"8965_CR12","first-page":"136","volume":"65","author":"A Ernaga Lorea","year":"2018","unstructured":"Ernaga Lorea A, Migueliz Bermejo I, Anda Api\u00f1\u00e1niz E et al (2018) Comparison of clinical characteristics of patients with follicular thyroid carcinoma and H\u00fcrthle cell carcinoma. Endocrinol Nutr 65:136\u2013142","journal-title":"Endocrinol Nutr"},{"key":"8965_CR13","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3904\/kjim.2014.29.3.325","volume":"29","author":"WG Kim","year":"2014","unstructured":"Kim WG, Kim TY, Kim TH et al (2014) Follicular and Hurthle cell carcinoma of the thyroid in iodine-sufficient area: retrospective analysis of Korean multicenter data. Korean J Intern Med 29:325\u2013333","journal-title":"Korean J Intern Med"},{"key":"8965_CR14","doi-asserted-by":"publisher","DOI":"10.3171\/CASE23263","author":"N Hameed","year":"2023","unstructured":"Hameed N, Hoppe MM, Habib A et al (2023) Surgical management of metastatic H\u00fcrthle cell carcinoma to the skull base, cortex, and spine: illustrative case. J Neurosurg Case Lessons. https:\/\/doi.org\/10.3171\/CASE23263","journal-title":"J Neurosurg Case Lessons"},{"key":"8965_CR15","first-page":"e37460","volume":"15","author":"PS Shirode","year":"2023","unstructured":"Shirode PS, D\u2019Cruz A, Chatterjee S et al (2023) Lenvatinib as a promising treatment option for unresectable H\u00fcrthle cell carcinoma: a case report. Cureus 15:e37460","journal-title":"Cureus"},{"key":"8965_CR16","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1089\/thy.2021.0424","volume":"32","author":"D Matsuura","year":"2022","unstructured":"Matsuura D, Yuan A, Wang L et al (2022) Follicular and Hurthle cell carcinoma: comparison of clinicopathological features and clinical outcomes. Thyroid 32:245\u2013254","journal-title":"Thyroid"},{"issue":"8","key":"8965_CR17","doi-asserted-by":"publisher","first-page":"925","DOI":"10.6004\/jnccn.2022.0040","volume":"20","author":"RI Haddad","year":"2022","unstructured":"Haddad RI, Bischoff L, Ball D et al (2022) Thyroid carcinoma, version 2.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Net 20(8):925\u2013951","journal-title":"J Natl Compr Cancer Net"},{"key":"8965_CR18","doi-asserted-by":"publisher","first-page":"5144","DOI":"10.1007\/s12325-021-01876-7","volume":"38","author":"A Coca-Pelaz","year":"2021","unstructured":"Coca-Pelaz A, Rodrigo JP, Shah JP et al (2021) H\u00fcrthle cell carcinoma of the thyroid gland: systematic review and meta-analysis. Adv Ther 38:5144\u20135164","journal-title":"Adv Ther"},{"issue":"2","key":"8965_CR19","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1001\/archotol.129.2.207","volume":"129","author":"N Bhattacharyya","year":"2003","unstructured":"Bhattacharyya N (2003) Survival and prognosis in H\u00fcrthle cell carcinoma of the thyroid gland. ARCH OTOLARYNGOL 129(2):207\u2013210","journal-title":"ARCH OTOLARYNGOL"},{"key":"8965_CR20","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s00259-020-04952-2","volume":"48","author":"V Wenter","year":"2021","unstructured":"Wenter V, Albert NL, Unterrainer M et al (2021) Clinical impact of follicular oncocytic (H\u00fcrthle cell) carcinoma in comparison with corresponding classical follicular thyroid carcinoma. Eur J Nucl Med Mol Imaging 48:449\u2013460","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"60","key":"8965_CR21","doi-asserted-by":"publisher","first-page":"101362","DOI":"10.18632\/oncotarget.20732","volume":"8","author":"Y Xiong","year":"2017","unstructured":"Xiong Y, Zhao Q, Li Z et al (2017) Propensity score matching analysis of the prognosis for the rare oxyphilic subtype of thyroid cancer (Hurthle cell carcinoma). Oncotarget 8(60):101362\u2013101371","journal-title":"Oncotarget"},{"key":"8965_CR22","doi-asserted-by":"publisher","first-page":"904986","DOI":"10.3389\/fendo.2022.904986","volume":"13","author":"C Chiapponi","year":"2022","unstructured":"Chiapponi C, Hartmann M, Schmidt M et al (2022) H\u00fcrthle cell carcinoma: single center analysis and considerations for surgical management based on the recent literature. Front Endocrinol (Lausanne) 13:904986","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"8965_CR23","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s00428-022-03422-4","volume":"482","author":"B Xu","year":"2023","unstructured":"Xu B, Lubin DJ, Dogan S et al (2023) Significance of oncocytic features in poorly differentiated thyroid carcinoma\u2013a bi-institutional experience. VIRCHOWS ARCH 482(3):479\u2013491","journal-title":"VIRCHOWS ARCH"},{"key":"8965_CR24","doi-asserted-by":"publisher","first-page":"3144","DOI":"10.1210\/clinem\/dgac448","volume":"107","author":"X Wang","year":"2022","unstructured":"Wang X, Zheng X, Zhu J et al (2022) Radiotherapy does not improve cancer-specific survival in H\u00fcrthle cell carcinoma of the thyroid. J Clin Endocrinol Metab 107:3144\u20133151","journal-title":"J Clin Endocrinol Metab"},{"key":"8965_CR25","doi-asserted-by":"publisher","first-page":"782646","DOI":"10.3389\/fonc.2021.782646","volume":"11","author":"H He","year":"2021","unstructured":"He H, Xu T, Li P et al (2021) Anti-PD-1 immunotherapy combined with stereotactic body radiation therapy and GM-CSF as salvage therapy in a PD-L1-positive patient with refractory metastatic thyroid H\u00fcrthle cell carcinoma: a case report and literature review. Front Oncol 11:782646","journal-title":"Front Oncol"}],"container-title":["European Archives of Oto-Rhino-Laryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-024-08965-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00405-024-08965-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-024-08965-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T18:47:53Z","timestamp":1738954073000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00405-024-08965-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,11]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["8965"],"URL":"https:\/\/doi.org\/10.1007\/s00405-024-08965-7","relation":{},"ISSN":["0937-4477","1434-4726"],"issn-type":[{"value":"0937-4477","type":"print"},{"value":"1434-4726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,11]]},"assertion":[{"value":"16 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The data analyzed in the present study was collected from the SEER database, which contained the de-identified information for patients; therefore, this article was exempted from approval by the Institutional Review Board.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}